gip and glp 1 drugs GLP-1 & Agonists | Obesity Diabetes Management | Harrison's updates (22nd Ed.) The GLP-1 Agonists and Obesity:
Description
Among those on the highest dose, 54.6% achieved at least 10% weight loss, 36.0% achieved 15% or more, and 18.4% achieved 20% or more
By utilizing this methodology, researchers have revealed that GLP-1RAs can exhibit affect the axon terminals of sensory neurons
Ratner RE, Rosenstock J, Boka G
doi: 10.1002/(sici)1096-9861(19990111)403:2 3.0.co;2-5 35 HolstJJ
Saxenda : Saxenda contains liraglutide and is a daily injection
